Transglutaminase 2 inhibitors and their therapeutic role in disease states
- 31 August 2007
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 115 (2), 232-245
- https://doi.org/10.1016/j.pharmthera.2007.05.003
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Structure–activity relationship study of novel tissue transglutaminase inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast CancerClinical Cancer Research, 2004
- Transglutaminases: crosslinking enzymes with pleiotropic functionsNature Reviews Molecular Cell Biology, 2003
- Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patientThe FASEB Journal, 2002
- Phospholipase Cδ1 Is a Guanine Nucleotide Exchanging Factor for Transglutaminase II (Gαh) and Promotes α1B-Adrenoreceptor-mediated GTP Binding and Intracellular Calcium ReleaseOnline Journal of Public Health Informatics, 2001
- The Length of Polyglutamine Tract, Its Level of Expression, the Rate of Degradation, and the Transglutaminase Activity Influence the Formation of Intracellular AggregatesBiochemical and Biophysical Research Communications, 1999
- GTP-dependent conformational changes associated with the functional switch between Gα and cross-linking activities in brain-derived tissue transglutaminaseJournal of Molecular Biology, 1998
- Localization of cellular transglutaminase on the extracellular matrix after wounding: Characteristics of the matrix bound enzymeJournal of Cellular Physiology, 1991
- Induction and activation of tissue transglutaminase during programmed cell deathFEBS Letters, 1987
- Enzymic basis for the Ca2+ion-induced crosslinking of membrane proteins in intact human erythrocytesBiochemistry, 1978